We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


CCS Supplies Frozen Cells from EMD Millipore’s Cell Line Panel

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "CCS Supplies Frozen Cells from EMD Millipore’s Cell Line Panel"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

CCS Cell Culture Service has signed a general license agreement with Millipore Corporation (EMD Millipore - a division of Merck KGaA, Darmstadt, Germany) that allows CCS to create bulk cell amounts from over 250 of EMD Millipore’s assay cell lines, enhancing customers’ drug discovery and high throughput functional screening capabilities.

With this agreement, CCS’s highly flexible service, which meets customers’ scale-up needs, becomes available for EMD Millipore's well-proven assay cell lines.

EMD Millipore owns more than 180 GPCR-expressing cell lines (ChemiScreen™, ChemiBrite™ lines) and 60 ion channel-expressing cell lines (PrecisION® lines).

From these, CCS can produce custom assay-ready frozen cells or membranes and may even use the cells as a host for transient bulk transfections.

Customers who have already licensed a cell line from EMD Millipore can order reagents prepared from this cell line from CCS without further approval by EMD Millipore.

Those who would like to get access to EMD Millipore’s technologies for the first time can license the cell line via CCS in a onestop-shop.

"Years of experience in frozen cell production makes CCS a reliable outsourcing partner for global pharmaceutical research”, stated Umesh A. Patel, Ph.D., Director, Lead Discovery, EMD Millipore.

Patel continued, “Customers relying on our GPCR and Ion Channel cell line products will be provided with a complete solution to support their drug discovery needs."

"I'm very glad that we can offer our services for EMD Millipore's cell lines now as well. This makes it very convenient for our customers to obtain high quality cell based reagents for their screening approaches", said Dr. Oliver Wehmeier, Managing Director and President of CCS.